NDC Compounded Drug 65302-527-15 Ketorolac Tromethamine; Bupivacaine Hydrochloride; Ketamine Hydrochloride
Injection Infiltration; Periarticular
Compounded Drug Product Information
Frequently Asked Questions
What is the NDC number assigned to Bupivacaine Hydrochloride, Ketorolac Tromethamine, Ketamine Hydrochloride?
Bupivacaine Hydrochloride, Ketorolac Tromethamine, Ketamine Hydrochloride was assigned by its manufacturer with NDC product code 65302-527. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Bupivacaine Hydrochloride, Ketorolac Tromethamine, Ketamine Hydrochloride?
The NDC package code 65302-527-15 was assigned to a 15 mL in 1 VIAL of ketorolac tromethamine; bupivacaine hydrochloride; ketamine hydrochloride administered infiltration; periarticular via injection.
Who manufactures this product?
Bupivacaine Hydrochloride, Ketorolac Tromethamine, Ketamine Hydrochloride is manufactured by an outsourced facility and labeled by The Ritedose Corporation. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.